Liriodenine enhances radiosensitivity in esophageal cancer ECA‑109 cells by inducing apoptosis and G2/M arrest
Authors:
Open Access
- 2 August 2018
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 16 (4) , 5020-5026
Abstract
At present, chemotherapy and radiotherapy represent the primary modalities of treatment for patients with unresectable esophageal squamous cell carcinoma (ESCC). However, the outcome of patients remains poor owing to radioresistance. The present study aimed to determine the radiosensitizing effect of liriodenine, an aporphine alkaloid derived from Enicosanthellum pulchrum, and investigating the underlying mechanisms in ESCC, using the esophageal cancer ECA‑109 cell line. Cellular proliferation was evaluated using the Cell Counting kit‑8 assay. Colony formation assay was performed to characterize the radiosensitive effects of liriodenine on ECA‑109 cells, and flow cytometry was used to detect the percentage of cells undergoing apoptosis. An immunofluorescence assay was utilized to evaluate the DNA damage repair ability. Western blotting was used to assess the protein levels of caspase‑3, B cell lymphoma‑2 (Bcl‑2) and Bcl‑2‑associated X (Bax). Liriodenine dose‑dependently inhibited ECA‑109 cell viability. The clonogenic survival assay demonstrated that liriodenine increased the radiosensitivity of ESCC cells, with a sensitization enhancement ratio of 1.11‑1.69. The results of flow cytometry demonstrated that liriodenine induced apoptosis and G2/M arrest. The immunofluorescence assay revealed that liriodenine delays DNA damage repair. The upregulation of Bax and Caspase‑3, and the suppression of Bcl‑2 confirmed that apoptosis was occurring. Liriodenine radiosensitizes ECA‑109 cells by inducing apoptosis and G2/M arrest. The findings of the present study indicated that liriodenine may represent an anticancer agent with promising potential for the treatment of ESCC.Keywords
This publication has 22 references indexed in Scilit:
- A platinum(II) complex of liriodenine from traditional Chinese medicine (TCM): Cell cycle arrest, cell apoptosis induction and telomerase inhibition activity via G-quadruplex DNA stabilizationJournal of Inorganic Biochemistry, 2014
- Bio-Functional Constituents from the Stems of Liriodendron tulipiferaMolecules, 2012
- Esophagectomy for T1 Esophageal Cancer: Outcomes in 100 Patients and Implications for Endoscopic TherapyThe Annals of Thoracic Surgery, 2009
- Radioresistance of Stat1 over-expressing tumour cells is associated with suppressed apoptotic response to cytotoxic agents and increased IL6-IL8 signallingInternational Journal of Radiation Biology, 2009
- Inhibition of expression of anti-apoptotic protein Bcl-2 and induction of cell death in radioresistant human prostate adenocarcinoma cell line (PC-3) by methyl jasmonateCancer Letters, 2008
- Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the WorldJournal of Clinical Oncology, 2006
- β-Phenylethylamines and the isoquinoline alkaloidsNatural Product Reports, 2006
- Apoptosis-inducing factor: vital and lethalTrends in Cell Biology, 2006
- Liriodenine inhibits the proliferation of human hepatoma cell lines by blocking cell cycle progression and nitric oxide-mediated activation of p53 expressionFood and Chemical Toxicology, 2005
- Predictive value of p53, Bcl2 and bax in the radiotherapy of head and neck cancerPathology and Oncology Research, 1997